ARRZX
Price
$13.12
Change
-$0.08 (-0.61%)
Updated
Jul 31 closing price
Net Assets
45.54M
FSMDX
Price
$42.33
Change
-$0.12 (-0.28%)
Updated
Jul 31 closing price
Net Assets
52.09B
Interact to see
Advertisement

ARRZX vs FSMDX

ARRZX vs FSMDX Comparison Chart in %
View a ticker or compare two or three
VS
ARRZX vs. FSMDX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRZX is a Hold and FSMDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 52.1B vs. ARRZX (45.5M). ARRZX pays higher dividends than FSMDX: ARRZX (1.02) vs FSMDX (0.76). ARRZX was incepted earlier than FSMDX: ARRZX (9 years) vs FSMDX (15 years). ARRZX (0.97) is less costly to investors than FSMDX (0.03). ARRZX is a more actively managed with annual turnover of: 92.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than ARRZX: FSMDX (0) vs ARRZX (5000000). FSMDX annual gain was more profitable for investors over the last year : 18.74 vs. ARRZX (-4.38). FSMDX return over 5 years is better than : 42.85 vs. ARRZX (-9.66).
ARRZXFSMDXARRZX / FSMDX
Total Expense Ratio0.780.033,120%
Annual Report Gross Expense Ratio0.970.033,880%
Fund Existence9 years15 years-
Gain YTD0.38314.6223%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/AN/A-
Net Assets45.5M52.1B0%
Annual Yield % from dividends1.020.76135%
Returns for 1 year-4.3818.74-23%
Returns for 3 years6.1550.0912%
Returns for 5 years-9.6642.85-23%
Returns for 10 yearsN/A165.64-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEMMX56.551.15
+2.08%
Fidelity Advisor Emerging Markets C
FFBFX31.340.12
+0.38%
Emerald Bkg & Finac Evolution - Inv
JGLYX21.55-0.01
-0.05%
JPMorgan Small Cap Growth R4
PQIPX15.59-0.05
-0.32%
PIMCO Dividend and Income I2
BIVRX18.50-0.21
-1.12%
Invenomic Investor